PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Ipsen telegraphs $400M deal for consumer healthcare split

After a lengthy strategic review, Ipsen’s plan to hive off its consumer healthcare (CHC) business is gaining traction. With the blessing of its board of directors...
Continue Reading →
News

ASCO GU: AstraZeneca, Merck’s Lynparza one-ups J&J’s Zejula with prostate cancer win regardless of gene mutations

AstraZeneca and Merck & Co.’s Lynparza may have a narrower label than GlaxoSmithKline’s rival drug Zejula in ovarian cancer, but in prostate cancer, the situatio...
Continue Reading →
News

Vertex’s Trikafta pricing central to cystic fibrosis treatment disparities, study says

The cost of a popular Vertex Pharmaceuticals therapy could be contributing to cystic fibrosis (CF) treatment disparities around the world, researchers argued in a re...
Continue Reading →
News

New management: Promising drug for people living with obesity

NICE recommends appetite-suppressing drugs which can reduce a patient’s by more than 10% The National Institute for Health and Care Excellence (NICE) has issued d...
Continue Reading →
News

Need for Speed: Kidney cancer patients waiting three times longer

Greater urgency for kidney cancer treatments as 40% of UK patients wait 84 days for a diagnosis A new survey by Kidney Cancer UK has revealed that two-fifths (40%...
Continue Reading →
News

Not so NICE: cancer patients miss out on innovative new treatments

Institute for Cancer Research highlights missed opportunities for NICE to reform its cancer drug assessment processes. National Institute for Health and Care Exce...
Continue Reading →
News

Parkinson’s UK and Domainex join forces to develop neuroinflammation therapies

Research collaboration between Parkinson’s UK and Domainex has the potential to improve 140,000 lives Parkinson’s UK and Domainex have announced a collaboration f...
Continue Reading →
News

Timely intervention: First chronic kidney disease treatment in 20 years

Significant landmark as NICE recommends AstraZeneca's chronic kidney disease treatment Forxiga The National Institute for Health and Care Excellence (NICE) has is...
Continue Reading →
News

Sanofi unveils new corporate brand and logo – unites the company under one purpose and a single identity

Sanofi unveiled a new bold and unifying corporate brand that supports the modernization and transformation the company launched in December 2019. Over the last 50...
Continue Reading →
News

Broadening horizons: positive CHMP opinion for expanding Ayvakyt

Ayvakyt receives a positive opinion from the CHMP for the treatment of adults with advanced systemic mastocytosis The Committee for Medicinal Products for Human U...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026